Key Legal Principles
Know the Rules. Protect the Patient.
Pharmaceutical access, reimbursement, commercial, medical affairs, and compliance professionals operate in an environment shaped by federal agencies, program administrators, state regulators, and other oversight bodies.
Legal Principles & Oversight Map
Federal & State Compliance Oversight
| Legal Principle | Primary Oversight Agency(ies) | What They Oversee |
|---|---|---|
1Patient Safety, Adverse Events & Product Complaints | Safety monitoring, pharmacovigilance, and timely reporting of adverse events and product complaints through required company processes. | |
|
2
Regulatory Compliance
|
Compliance with approved labeling, promotion, manufacturing, and post-market requirements. | |
3Truthful, Non-Misleading & Ethical Communications | Communications and promotional activities that are truthful, balanced, appropriately substantiated, and consistent with approved labeling and applicable rules. | |
|
4
Anti-Kickback & Improper Inducements
|
Enforcement of the Anti-Kickback Statute, False Claims Act, and fraud investigations. | |
5Physician Self-Referral (Stark Law) | Financial relationships that can affect referrals for designated health services paid by Medicare or Medicaid. A Stark exception does not automatically resolve Anti-Kickback Statute risk. | |
6Patient Assistance, Copay Support & Beneficiary Inducements | Financial assistance, copay support, free-drug programs, and anything of value offered to Federal health care program beneficiaries must follow applicable law and company policy. | |
|
7
Patient Privacy & Confidentiality
|
Privacy, security, and breach-notification requirements for protected health information under HIPAA. | |
|
8
Fair Competition (Antitrust)
|
Anti-competitive conduct, mergers, monopolization, and collusion. | |
|
9
Transparency (Payments to HCPs)
|
Administration of the Open Payments Program, also known as the Sunshine Act. | |
|
10
Product Quality & Manufacturing
|
Good Manufacturing Practice, inspections, recalls, and quality systems. | |
|
11
Accurate Documentation & Recordkeeping
|
Data integrity, documentation accuracy, and records supporting regulatory compliance. | |
12Drug Supply Chain Security | Product tracing, authorized trading partners, and response procedures for suspect or illegitimate products across distribution and pharmacy channels. | |
13REMS Compliance | FDA-required Risk Evaluation and Mitigation Strategy requirements, which may include enrollment, certification, dispensing, monitoring, and documentation controls. | |
14Program Integrity, Claims & Overpayments | Accurate claims and reimbursement practices; credible concerns about an overpayment, false claim, fraud, waste, or abuse should be escalated through the organization’s established process. | |
15340B Program Integrity | Covered-entity eligibility, diversion prevention, duplicate-discount safeguards, and verification of current program and contract-pharmacy requirements. | |
16Exclusion Screening | Screening employees, contractors, vendors, and relevant entities against exclusion lists, including applicable state Medicaid lists, under organizational policy. | |
17State Law & Payer-Contract Compliance | State privacy, pharmacy, insurance, and drug-pricing requirements—and payer contracts—may be more specific or restrictive than federal rules. Verify the applicable state and plan requirements. | |
18Corporate Integrity Agreements & Effective Compliance Programs | Corporate Integrity Agreements are enforcement remedies for some organizations; effective compliance programs support training, reporting, oversight, and corrective action. |
Additional Organizations That Influence Pharmaceutical Compliance
Pharmaceutical access, reimbursement, commercial, medical affairs, and compliance professionals operate in a complex environment shaped by multiple federal agencies and oversight bodies.
Centers for Medicare & Medicaid Services
Oversees Medicare, Medicaid, reimbursement policies, and the Open Payments Program.
Visit CMS →Health Resources and Services Administration
Administers the 340B Drug Pricing Program and oversees covered-entity participation, eligibility, and program requirements.
Visit HRSA 340B →U.S. Food and Drug Administration
Regulates the safety, efficacy, manufacturing, labeling, and promotion of drugs and biologics.
Visit FDA →Office of Inspector General
Publishes compliance guidance, Safe Harbors, advisory opinions, and investigates healthcare fraud.
Visit HHS OIG →U.S. Department of Justice
Prosecutes violations involving fraud, bribery, kickbacks, and False Claims Act cases.
Visit DOJ FCA Resource →Office for Civil Rights
Enforces HIPAA privacy, security, and breach notification rules.
Visit HHS OCR HIPAA →Federal Trade Commission
Oversees advertising practices for certain products, competition, and antitrust laws.
Visit FTC Health Care Competition →Office of Prescription Drug Promotion
A division within the FDA responsible for reviewing prescription drug promotional materials and ensuring they are truthful, balanced, and not misleading.
Visit FDA OPDP →Practical Compliance Awareness
This framework provides a practical overview of the agencies most relevant to pharmaceutical professionals, especially those in access, reimbursement, commercial, medical affairs, and compliance roles.